Voyager Therapeutics (VYGR) Gains from Investment Securities (2014 - 2026)

Voyager Therapeutics has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $708348.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $708348.0, down 93.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $708348.0 (down 93.62% YoY), and the FY2025 annual result was $1.4 million, down 85.47% from the prior year.
• Gains from Investment Securities came in at $708348.0 for Q1 2026 at Voyager Therapeutics, up from -$62000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $11.1 million in Q1 2025 to a low of -$2.3 million in Q4 2022.
• The 5-year median for Gains from Investment Securities is $1.3 million (2022), against an average of $2.3 million.
• Across the five-year window, Gains from Investment Securities sank 100.64% in 2023 and jumped 20349.08% in 2024, its largest moves.
• Voyager Therapeutics' Gains from Investment Securities stood at -$2.3 million in 2022, then jumped by 98.49% to -$35000.0 in 2023, then advanced by 8.57% to -$32000.0 in 2024, then plunged by 93.75% to -$62000.0 in 2025, then jumped by 1242.5% to $708348.0 in 2026.
• The last three Gains from Investment Securities figures came in at $708348.0 (Q1 2026), -$62000.0 (Q4 2025), and $926636.0 (Q3 2025), per Business Quant data.